In this study, researchers sought to determine the impact of the FDA’s Accelerated Approval pathway among patients with solid tumors.

Overall survival data showed a 50% reduction in the risk of death with the regimen compared with surgery alone.

High rates of vulnerability on a geriatric assessment were identified in a cohort of fit patients aged 60 years or older with acute myeloid leukemia.

(HealthDay News) — For women with a history of breast cancer, real (RA) and sham acupuncture (SA) produce clinically meaningful improvements in perceived cognitive impairment, according to a study ...